Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORONALTITUDE: COVID-19 and Hypoxia Sensitivity
NCT05167357Completed
- Sponsor
- IFREMMONT
- Start
- Jan 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by IFREMMONT. Primary endpoints: Desaturation induced by hypoxia at exercise, Hypoxic cardiac response at exercise and 1 more. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT05167357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05167357.